AI Article Synopsis

  • * Researchers developed a strong protocol to culture mesothelial progenitor cells (MPCs) from pig and mouse thorax, discovering that BMP4 aids in differentiation into smooth muscle cells, while FGF2 helps expand the MPC pool but inhibits this differentiation.
  • * The study highlighted key signaling pathways involving BMP4, FGF2, and a Wnt activator (CHIR99021) that regulate MPC behaviors, offering insights into potential mechanisms underlying mesothelial cell functions and their role in conditions like mesothelioma.

Article Abstract

Mesothelial cells, in the outermost layer of internal organs, are essential for both organ development and homeostasis. Although the parietal mesothelial cell is the primary origin of mesothelioma that may highjack developmental signaling, the signaling pathways that orchestrate developing parietal mesothelial progenitor cell (MPC) behaviors, such as MPC pool expansion, maturation, and differentiation, are poorly understood. To address it, we established a robust protocol for culturing WT1 MPCs isolated from developing pig and mouse parietal thorax. Quantitative qPCR and immunostaining analyses revealed that BMP4 facilitated MPC differentiation into smooth muscle cells (SMCs). In contrast, FGF2 significantly promoted MPC progenitor pool expansion but blocked the SMC differentiation. BMP4 and FGF2 counterbalanced these effects, but FGF2 had the dominant impact in the long-term culture. A Wnt activator, CHIR99021, was pivotal in MPC maturation to CALB2 mesothelial cells, while BMP4 or FGF2 was limited. Our results demonstrated central pathways critical for mesothelial cell behaviors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11456698PMC
http://dx.doi.org/10.3389/fcell.2024.1387237DOI Listing

Publication Analysis

Top Keywords

parietal mesothelial
12
mesothelial progenitor
8
smooth muscle
8
mesothelial cells
8
mesothelial cell
8
pool expansion
8
bmp4 fgf2
8
mesothelial
6
fgf2
5
mpc
5

Similar Publications

Article Synopsis
  • - Malignant peritoneal mesothelioma (MPM) is a rare and aggressive cancer that starts from the mesothelial cells in the abdominal cavity, typically leading to poor outcomes.
  • - A case study of a 79-year-old man revealed his worsening abdominal pain and ascites, alongside a significant smoking history and occupational exposure as a plumber, but no prior asbestosis diagnosis.
  • - Diagnostic imaging and histopathological tests confirmed MPM, emphasizing the need to consider this cancer in patients with ascites and histories of potential asbestos exposure during occupational activities.
View Article and Find Full Text PDF
Article Synopsis
  • * Researchers developed a strong protocol to culture mesothelial progenitor cells (MPCs) from pig and mouse thorax, discovering that BMP4 aids in differentiation into smooth muscle cells, while FGF2 helps expand the MPC pool but inhibits this differentiation.
  • * The study highlighted key signaling pathways involving BMP4, FGF2, and a Wnt activator (CHIR99021) that regulate MPC behaviors, offering insights into potential mechanisms underlying mesothelial cell functions and their role in conditions like mesothelioma.
View Article and Find Full Text PDF

In physiological conditions, the pleural space couples the lung with the chest wall and contains a small amount of fluid in continuous turnover. The volume of pleural fluid is the result from the balance between the entry of fluid through the pleural capillaries and drainage by the lymphatics in the most dependent areas of the parietal pleura. Fluid filtration is governed by Starling forces, determined by the hydrostatic and oncotic pressures of the capillaries and the pleural space.

View Article and Find Full Text PDF

Background: Peritoneal fibrosis (PF) is a major, persistent complication of prolonged peritoneal dialysis that eventually leads to peritoneal ultrafiltration failure and termination of peritoneal dialysis. Prolonged exposure to high glucose concentrations, degradation products, uremic toxins, and episodes of peritonitis can cause some changes in the peritoneal membrane, resulting in intraperitoneal inflammation and PF, leading to failure of ultrafiltration and dialysis. CA-125 can be used as a biomarker of peritoneal mesothelial cell count in the peritoneal dialysate and for monitoring cell count in PD patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!